Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
71.1M
-
Shares change
-
+1.67M
-
Total reported value, excl. options
-
$2.62B
-
Value change
-
+$58.4M
-
Put/Call ratio
-
0.88
-
Number of buys
-
112
-
Number of sells
-
-140
-
Price
-
$36.79
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q2 2025
298 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q2 2025.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.1M shares
.
Largest 10 shareholders include ARK Investment Management LLC (6.4M shares), BlackRock, Inc. (6.28M shares), VANGUARD GROUP INC (5.83M shares), Artisan Partners Limited Partnership (5.06M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (3.91M shares), STATE STREET CORP (2.5M shares), EdgePoint Investment Group Inc. (2.39M shares), Invesco Ltd. (2.35M shares), Nikko Asset Management Americas, Inc. (2.3M shares), and Sumitomo Mitsui Trust Group, Inc. (2.3M shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.